World Orphan Drug Congress, WODC, Europe will be taking place in Amsterdam this year.
We are delighted to share that Decisive Consulting will attend the World Orphan Drug Congress, WODC, in Amsterdam in October!
Come and meet Chris Grimes Compton, Steven Fountain, Tammy Wynne, Rosa Willock and Sophia Naegeli, at Stand 10.312– we’d love to connect!
From January, 13th 2028, the Joint Clinical Assessment (JCA) becomes mandatory for orphan drugs. This will create a whole new landscape for ensuring access to medicines indicated to treat rare diseases. Join us for a conversation about understanding your JCA readiness with our free online self-assessment and discuss solutions we can co-create!
🗓️ Pre-Congress Workshops: 27 October 2025
🗓️ Main Congress: 28-29 October 2025
Let’s collaborate to find innovative solutions to advance treatments that make a real difference in the lives of rare disease patients!